HbA1C Hemoglobin Test for Diabetes

A hemoglobin HbA(1C) assay is designed to provide doctors with the data they need to monitor the diabetes of patients and prescribe the appropriate treatment.

Early diagnosis and monitoring of diabetes is key to managing and preventing serious complications and premature death. The assay provides precise and accurate test results and can be run on the Architect c8000, ci200, and Aeroset immunochemistry systems of Abbott Laboratories (Abbott Park, IL, USA). The assay is called Multigent HbA(1C). Although the test was developed jointly with Seradyn (Indianapolis, IN, USA), Abbott will be the exclusive distributor of the Multigent test. Seradyn is a diagnostic reagent developer in the areas of therapeutic drug monitoring and human serology.

While home blood-glucose monitoring gives diabetes patients information they need daily, it is also important for them to assess the overall control of blood sugars by monitoring glycohemoglobin A(1C).

"This is a routine lab test that all doctors are running on their patients with diabetes every three to four months, and changes in treatment, diet, and exercise programs are based on these results,” noted Arturo R. Rolla, M.D., associate clinical professor of medicine at Harvard Medical School.




Related Links:
Abbott